Fran Drescher: Living "Old School" to Prevent Cancer

While spending weeks in the hospital for acute myeloid leukemia, I tried eight fun things to keep me busy.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.

The first FDA-approved systemic therapy may be beneficial to patients with low-grade astrocytoma or oligodendroglioma with IDH1 or 2 mutations.

In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.

The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery.

I wish my doctor was more upfront — sharing both the realities and the glimmers of hope — the day I was diagnosed with brain cancer.